Texas Medical Association (TMA) spotlighted the physician’s role in providing Pre-exposure Prophylaxis (PrEP) and provided in depth information on access to, efficacy of and target groups for PrEP. While treatment for an STD might be conversation starter about PrEP, PrEP is not just for STD clinicians. Primary care physicians, Ob/Gyn specialists, and others may all … Continue reading PrEP for HIV in Texas
Pre-exposure prophylaxis regimens containing Selzentry were generally safe and well-tolerated compared with Truvada, the standard-of-care PrEP drug, according to the results of a phase 2 trial.
The DSHS HIV/STD Prevention and Care Branch announces this Request for Application (RFA) to provide sustainable, integrated, routine, opt-out screening for HIV in healthcare settings in hospital systems emergency services and primary care in community health centers that serve under- and uninsured populations in high morbidity areas in Texas.
According to a retrospective study of data, women at risk for HIV are not participating in PrEP treatment. The researchers recommend targeted intervention plans to increase use among people most likely to benefit from it.
HIV testing recommendations for women: An important step to achieving perinatal HIV elimination was presented on August 19 by the CDC and partners and has been archived for those that missed it. The session focuses on the rationale for testing women, understanding the new HIV Algorithm and how it impacts providers when ordering and interpreting tests, and some examples of missed opportunities in HIV prevention.
According to a new modeling study, HIV incidence could be reduced by one third if almost half of eligible men who have sex with men participated in PrEP. Treatment adherence is an important aspect in the model. Targeting individuals at a substantial risk for transmission is also key.
The Department of State Health Services will host the 2016 Test Texas Coalition Summit on May 12-13, 2016 in Austin, Texas. The purpose of this meeting is to convene DSHS Routine HIV Screening contractors and key stakeholders to review and discuss current issues related to Routine HIV Screening program implementation and sustainability. Day one of … Continue reading Test Texas Summit
Anthony Fauci summarizes recent research on the timing of ART and the efficacy of PrEP for prevention in this New England Journal of Medicine article. He calls for the resources and political will to increase HIV testing and treatment globally. Learn More about ART Program